… binding of tobramycin to mucin in the sputum of cystic fibrosis patients, … It is also important to
note that cystic fibrosis patients are … with respect to tobramycin MIC. One study demonstrated …

… Though tobramycin inhalation solution has been used for … and reduce exacerbations in
patients with cystic fibrosis (CF), … of tobramycin inhaled solution and mortality in patients with CF …

… of tobramycin solution for inhalation (TSI; TOBI®, Chiron Corp.) on lung function decline rate
in 400 young persons with cystic fibrosis … of inhaled tobramycin in patients with cystic fibrosis …

… patients is variable, and based both on the infecting species and individual clinician
experience. Tobramycin solution … of pseudomonal infections in patients with cystic fibrosis.7, 8 A …

… an inhaled parenteral solution. Subsequently, a specific tobramycin inhalation solution was
… of two inhaled tobramycin solutions in cystic fibrosis patients with Pseudomonas aeruginosa …

… Direct aerosol delivery of aminoglycosides such as tobramycin to the lower airways of
patients with cystic fibrosis may control infection with Pseudomonas aeruginosa and improve …

… tobramycin solution for inhalation (TSI) administered twice daily for 4 weeks in 74 bronchiectasis
patients colonized … Data from a trial of TSI in cystic fibrosis (CF) patients 6 are shown for …

… Fibrosis Foundation (CFF) guidelines strongly recommend eradication therapy with tobramycin
inhaled solution (… placebo in 520 patients with a diagnosis of cystic fibrosis and a positive …

… Chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis (CF) causes
… the efficacy and tolerability of a tobramycin highly concentrated solution for inhalation (TSI) […

… and improve patient convenience and satisfaction. We evaluated the safety, efficacy and
convenience of tobramycin inhalation powder (TIP™) versus tobramycin inhalation solution (TIS…